INTRODUCTION
The mammalian glucokinase (GK) is a key enzyme of glucose utilization, playing a crucial role in maintaining blood glucose homoeostasis. In contrast with the other hexokinase family members (hexokinases I-III), the GK (hexokinase IV) has a lower affinity for glucose with sigmoidal kinetics and is not inhibited by its reaction product glucose 6-phosphate [1] [2] [3] [4] [5] . GK expression is restricted to hepatocytes [6] , the pancreatic β-cells and some neuroendocrine cells of the gastrointestinal tract [7] .
In the liver, the glycolytic enzymes GK and pyruvate kinase show a slight predominance in the less aerobic, perivenous zone, whereas the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and glucose 6-phosphatase were found in the more aerobic, periportal zone [8] .
The GK gene can be transcribed from two different promoters. An extrahepatic expression is initiated from the β-cell-specific promoter which is localized approx. 20 kb upstream of the GK gene, whereas the hepatocytic expression is controlled by the liver-specific promoter adjacent to the GK gene [9, 10] . A number of binding sites for transcription factors were found in the liverspecific GK promoter by DNase-I footprint assays. However, not all the regulatory transcription factors regulating the GK gene expression are known yet, except for the upstream stimulatory factor 1 [11] and the sterol regulatory element binding protein 1c [12] . The P1 region k54\k35 [11] of the GK promoter identified by footprint analysis with nuclear proteins from rat liver contains a direct repeat-like sequence of an hexanucleotide consensus nuclear receptor binding site [13] , which could be a target for the hepatic nuclear factor 4 (HNF-4).
HNF-4 is a member of the steroid\thyroid superfamily and exists in various isoforms [13] [14] [15] [16] [17] [18] . In addition to the liver, HNF-4α is expressed in the kidney, pancreas, small intestine, testis and colon, whereas HNF-4γ was not detectable in the liver [15] . The active HNF-4 binds DNA as a homodimer and, at present, there is no evidence that HNF-4 forms heterodimers with other members of the nuclear receptor family [13, 19] .
It has been demonstrated that HNF-4α is critical for embryonic development : targeted disruption of the mouse HNF-4α gene has been found to be lethal [20] . HNF-4 is known to be important for glucose and lipid homoeostasis [21] [22] [23] [24] [25] , because mutations in the HNF-4 gene can cause maturity-onset diabetes of the young (MODY-1).
Since HNF-4 is important for the appropriate expression of genes regulating glucose and lipid metabolism and since the P1 site contains a putative HNF-4 element, the aim of the present study was to investigate the role of HNF-4α as a factor involved in the regulation of GK expression in primary cultured rat hepatocytes. We demonstrate that HNF-4α may function as a transcriptional activator for the GK expression and that, together with the O # gradient, HNF-4α may regulate the zonated GK gene expression in liver.
EXPERIMENTAL
All biochemicals and enzymes were of analytical grade and were purchased from commercial suppliers.
Animals
Male Wistar rats (200-260 g) were kept on a 12 h day-night rhythm (light from 07:00 to 19:00 h) with free access to water and food. Rats were anaesthetized with pentobarbital (60 mg\kg body weight) before the preparation of hepatocytes between 08:00 and 09:00 h.
Plasmid constructs
The reporter plasmid rat GK-1430 LUC (luciferase) was constructed by inserting a Bgl II-HindIII GK promoter fragment (k1430\j21) into pGL3 basic from Promega (Heidelberg, Germany). The reporter plasmid GK-101 LUC was constructed by inserting a SmaI-XhoI promoter fragment (k101\j79) [26] into pGL3 basic. The plasmid GK-101 HNFm LUC was constructed by PCR, using the reporter plasmid GK-101 LUC and the oligonucleotide primer pair HNFm (5h-CCCTGGCCCTGAatTcGTGACACT-3h) containing a mutated HNF-4 sequence together with the RV3 (Promega) or GL2 (Promega) primer to amplify 150 and 200 bp fragments. With a second PCR using the RV3 and GL2 primer, a 350 bp fragment was generated which was cloned into the SmaI and HindIII sites of pGL3 basic. All constructs were verified by sequencing in both directions.
The expression plasmid pCMX-HNF-4 containing the fulllength rat HNF-4α1 cDNA was described previously [27, 28] .
Cell transfection and LUC assay
Liver cells were isolated by collagenase perfusion and were maintained under standard conditions in an atmosphere of periportal pO
, by vol.) in medium M199 containing 1 nM of insulin added as a growth factor for culture maintenance, 100 nM dexamethasone required as a permissive hormone and, until the first change of medium after 5 h, 4% (v\v) neonatal-calf serum. Transfections were essentially performed as described in [29] : in brief, 2.5 µg of DNA was precipitated in 150 µl of transfection buffer [7. 5 µl CaCl # \75 µl of 2iHepes (pH 7.05)\67.5 µl H # O] and was added to 10' freshly isolated hepatocytes for 5 h. In HNF-4α co-transfection assays, 2 µg of the LUC constructs were transfected with 500 ng of pCMX-HNF-4, whereas in controls they were transfected with 500 ng of the empty vector. After 5 h, the medium was changed and the cells were cultured under periportal pO # for up to 24 h. Then, the medium was changed again, and the cells were further cultured for another 24 h under periportal (16
RNA preparation and Northern-blot analysis
Total RNA was prepared from 3i10' cells as described previously [30] . RNA (15 µg) was denatured using formaldehyde and used in a typical Northern-blot experiment. Digoxigenin (DIG)-labelled antisense GK and β-actin RNA served as hybridization probes ; they were generated by in itro transcription from pBS-GK1, pBS-β-actin using T3 RNA polymerase and DIG-UTP. Hybridizations were carried out with 50 ng\ml transcript at 68 mC for 6 h according to the manufacturer's application notes for the DIG-nucleic acid detection kit (Roche, Mannheim, Germany). Detection of hybrids was performed as described previously [30] . Blots were quantified with a videodensitometer (Biotech Fischer, Reiskirchen, Germany).
Western-blot analysis and GK enzyme-activity assay
For Western-blot analysis, protein from primary-cultured hepatocytes and transiently transfected hepatocytes was isolated as described previously [31] . The protein content was determined using the Bradford method. Protein (50 µg) was dissolved in a 27 µl SDS sample buffer [32] , loaded on a SDS-10 % polyacrylamide gel and after electrophoresis blotted on nitrocellulose membranes. Non-specific binding was blocked with a blocking buffer [10 mM Tris\HCl (pH 7.5), 100 mM NaCl, 0.1 % (v\v) Tween 20, 10 % (w\v) milk powder]. Blots were incubated with a primary goat antibody raised against amino acids 2-20 of the human GK (Santa Cruz, Heidelberg, Germany) in a 1 : 200 dilution or with a 1 : 1000 dilution of the goat antibody raised against the 18 C-terminal amino acids of human HNF-4α (Santa Cruz) in blocking buffer overnight at 4 mC. Washing was performed with blocking buffer without milk powder. The secondary antibodies were an anti-goat IgG (Dako, Hamburg, Germany) used in a 1 : 2000 dilution for 1 h. After washing for 30 min, the ECL2 Western-blotting system (Amersham, Freiburg, Germany) was used for detection. Under these conditions, GK was visible as a band of 53 kDa and HNF-4α as a band of 54 kDa. For determining the GK enzyme activity, cells were washed with 0.9 % NaCl, scraped in a buffer containing 50 mM Hepes (pH 7.5), 100 mM KCl, 5 mM MgCl # , 1 mM EDTA, 2.5 mM dithioerythritol, 10 mg\ml BSA and homogenized with an Ultraturrax (Jahnke and Kunkel, Stauffen). GK activity was then essentially recorded as in [33] and DNA was estimated as described previously [34] .
Preparation of nuclear extracts
Nuclear extracts were prepared by modification of a standard protocol [35, 36] with buffers A and C containing 0.5 mM dithioerythritol (Sigma, Taufkirchen, Germany), 0.4 mM PMSF (Serva, Heidelberg, Germany), 2 µg\ml leupeptin and pepstatin (Roche), 2 µg\ml aprotinin (Bayer, Leverkusen, Germany), 1 mM sodium vanadate (Sigma) and the ' complete ' protease inhibitor cocktail tablets (Roche), essentially as described in [37] .
Electrophoretic mobility-shift assay (EMSA)
The sequence of the GK-HNF-4-WT (WT, wild-type) oligonucleotide was 5h-CCCTGGCCCTGACCTTGTGACACT-3h, whereas the sequence of the GK-HNF-4-m oligonucleotide contains a 3 bp exchange to generate the sequence 5h-CCCTGGCCCTGAatTcGTGACACT-3h. Equal amounts of complementary oligonucleotides were annealed, and labelled by 5h-end labelling with [γ-$#P]ATP (Amersham, Freiburg, Germany) and T4 polynucleotide kinase (MBI, St. Leon-Rot, Germany). They were purified with the Nucleotide Removal Kit (Qiagen, Hilden, Germany). Binding reactions were carried out in a total volume of 20 µl, containing 50 mM KCl, 1 mM MgCl # , 1.1 mM EDTA, 5 % (v\v) glycerol, 10 µg of nuclear extract, 250 ng poly d(I-C) and 5 mM dithioerythritol. After preincubation for 5 min at room temperature, 1 µl of the labelled probe (10% c.p.m.) was added and the incubation was continued for an additional 10 min. For supershift analysis, 2 µl of HNF-4α antibody was added to the EMSA reaction which was then incubated at 4 mC for 2 h. The electrophoresis was then performed with a 5 % (w\v) nondenaturing polyacrylamide gel in TBE (89 mM Tris\89 mM boric acid\5 mM EDTA) buffer at 200 V. After electrophoresis the gels were dried and exposed to a PhosphorImager screen.
RESULTS

Enhancement of GK mRNA, enzyme activity and protein levels by perivenous pO 2 and overexpression of HNF-4α in rat hepatocytes
Primary hepatocytes were investigated to discover whether the transfection of rat HNF-4α expression vectors could enhance the GK mRNA, protein and enzyme activity level under periportal and perivenous pO # . For comparison, GK mRNA and enzyme activities were measured after treatment of hepatocytes with 1 nM insulin. Under arterial pO # , in the absence of insulin, GK mRNA was nearly undetectable, whereas under perivenous pO # , GK mRNA was detectable. Insulin elevated GK mRNA within 3 h, maximally to approx. 700 % under venous pO # and to a lower level of approx. 400 % under arterial pO # (Figure 1 ). This positive modulation of GK mRNA induction was in line with a previous study [30] . The transfection of hepatocytes with the HNF-4α expression vector enhanced GK mRNA levels to approx. 600 % under both arterial and venous pO # when compared with the perivenous control (Figure 1) . The HNF-4-mediated GK mRNA induction was followed by an increase in GK enzyme activity on the basis of enhanced GK protein levels. In the controls under arterial pO # , GK enzyme activity was in the range of 0.1 µmol : min −" : mg −" DNA, whereas under venous pO # , GK enzyme activity was enhanced to approx. 0.25 µmol : min −" : mg −" DNA. Insulin enhanced GK activity to approx. 0.7 and 1.2 µmol : min −" : mg −" DNA under arterial and venous pO # respectively, in line with a previous study [38] . The overexpression of HNF-4 increased GK activity to 1.2 µmol : min −" : mg −" DNA under arterial pO # and to 1.1 µmol : min −" : mg −" DNA under perivenous pO # . The increases in GK enzyme activity were due to the enhanced GK protein levels. In the untransfected cells, GK protein was enhanced by approx. 6-fold under perivenous pO # compared with periportal pO # . After transfection of the HNF-4α expression vector, the GK protein level was enhanced by approx. 12-fold under periportal pO # and by approx. 14-fold under perivenous pO # , compared with the untransfected control under arterial pO # (Figure 2) . Interestingly, the HNF-4α levels were increased by approx. 8-fold under perivenous pO # (8 % O # ). The transfection of the HNF-4α vector enhanced the HNF-4 level by approx. 20-fold under periportal pO # and by approx. 17-fold under perivenous pO # compared with the untransfected control under arterial pO # (Figure 2) . Thus, in rat hepatocytes, transfection of HNF-4α expression vectors increased GK mRNA, protein and enzyme activity levels 
Activation of transfected rat GK promoter LUC gene constructs by HNF-4α in rat hepatocytes
As the next step, the ability of HNF-4α to activate the liverspecific GK promoter was tested by co-transfection of rat liver GK promoter LUC gene constructs together with an expression vector encoding the rat HNF-4α1 isoform.
The co-transfection of GK-1430 LUC, a construct containing the entire liver-specific GK promoter and the HNF-4α vector induced LUC activity by approx. 5-fold (Figure 3 ). Then, a largely shortened 101 bp fragment of the GK promoter that still contained the potential HNF-4 element, was used to drive the LUC gene in pGL3 basic (GK-101 LUC) (Figure 3) . In comparison with GK-1430 LUC, hepatocytes transfected with GK-101 LUC displayed approx. 2-fold higher basal LUC activity which is in line with a previous study [26] . But again, after co-transfection of hepatocytes with GK-101 LUC and HNF-4α, the LUC activity was enhanced by approx. 2-fold. In contrast, after co-transfection of the GK-101 HNFm LUC containing a mutation inside the HNF-4 recognition site HNF-4α did not activate LUC activity (Figure 3) . These results demonstrated that the GK promoter can be activated by HNF-4α via the HNF-4 binding element inside the P1 region.
Figure 3 Activation of GK promoter-controlled LUC expression by overexpression of HNF-4α via the HNF-4 binding element in rat hepatocyte cultures
Binding of HNF-4α to the HNF-4 binding element of the rat GK promoter
To corroborate further the conclusion from the transfection experiments that HNF-4α interacts with the HNF-4 binding element of the GK promoter (GK-HNF), the binding of nuclear proteins to the GK-HNF was examined by EMSA. The GK-HNF-4-WT oligonucleotide (k61\k38) (Figure 4 ) was able to bind three complexes. In addition to the largest and the smallest constitutive protein complex, a hypoxia-inducible nuclear protein complex was detectable (Figure 4) . To investigate the presence of HNF-4α in these complexes, an antibody against HNF-4α was included in the binding reaction. Addition of the HNF-4α antibody to the EMSA reaction strongly reduced the formation of the hypoxia-inducible DNA complex with the GK-HNF-4- WT oligonucleotide (Figure 4) . Furthermore, this hypoxiainduced DNA protein complex was no longer detectable by using the mutated GK-HNF-4-m oligonucleotide, whereas the constitutive complexes were still formed. These complexes were not affected in the presence of anti-HNF-4α (Figure 4) . These results indeed corroborate the transfection studies and indicate that HNF-4α can interact at the HNF-4 binding element in the GK promoter.
Figure 4 Binding of HNF-4α to the rat GK-HNF-4 element
DISCUSSION
In the present study, it has been shown that in primary hepatocytes the GK expression can be activated by HNF-4α (Figure 1 ). Transient transfection of GK promoter LUC gene constructs GK-1430 LUC, GK-101 LUC and GK-101 HNFm LUC together with the HNF-4α expression vector show that HNF-4α can enhance LUC activity via the HNF element (k52\k39) in primary rat hepatocytes (Figure 3) . The interaction of HNF-4α at the GK-HNF-responsive element can be demonstrated by EMSA (Figure 4 ). Thus it has been shown for the first time that HNF-4α can influence the GK gene activation via the HNF-4 site in the P1 region.
HNF-4 as a regulator of developmental and nutrient-dependent gene expression
HNF-4 responsive elements have been identified in genes, the expression of which is essential for lipid-glucose homoeostasis, e.g. apolipoprotein genes ApoB, ApoCIII, ApoAII, glucose transporter 2 and the glycolytic enzyme genes aldolase B, glyceraldehyde-3-phosphate dehydrogenase and the pyruvate kinase type liver (PK L ). HNF-4 is also essential for the expression of gene products which are responsible for the proliferation and differentiation of red blood cells such as erythropoietin (EPO) [21] [22] [23] [24] [25] 27] . Several of these genes contain HNF-4 responsive elements which only matched the HNF-4 consensus sequence [13] in 9 or 11 of 12 positions, but they were all functionally active [27, [39] [40] [41] . Moreover, the GK-HNF-4 responsive element (k52\k39) in the rat GK promoter matched the HNF-4 consensus site in 11 of 12 positions and was functionally active. However, the HNF-4 responsive element of the GK promoter does not appear to be an optimal HNF-4 responsive element, since the direct repeats of the element are separated by only two nucleotides. The influence of different nucleotide numbers between the HNF-4 repeats was tested in EMSAs by using nuclear extracts from COS cells transfected with an HNF-4 WT expression vector [42] . It was demonstrated that HNF-4 WT bound with high affinity to a response element consisting of a direct repeat separated by one nucleotide, whereas a direct repeat separated by two nucleotides reduced binding of HNF-4 WT and the direct repeat without spacer almost completely suppressed binding of HNF-4 WT. Thus, despite the fact that GK-HNF-4 element does not represent a high-affinity binding site, it remained functionally active.
GK is a key enzyme in glucose utilization and the results from embryonic stem cells lacking the HNF-4 gene have shown the importance of HNF-4 for the expression of genes, products of which are involved in glucose metabolism. Thus, the expression of genes encoding glucose transporter 2, and the glycolytic enzymes aldolase B, glyceraldehyde-3-phosphate dehydrogenase and the PK L is reduced in HNF-4α-deficient (k\k) embryonic stem cells [25, 43] . In the study with HNF-4 k\k embryonic stem cells, the GK gene expression appeared to be unaffected. The reason for this could be that GK first appears in the liver of rats 2 weeks after birth and after weaning [44, 45] .
Both, GK and HNF-4α have been shown to be responsible for MODY. Both, MODY1 with a defective HNF-4 gene and MODY2 caused by GK gene mutations, are autosomal-dominant inherited diseases and characterized by defective insulin secretion of the β-cells of the pancreas [24, 46, 47] . Thus in MODY1 patients, hepatic glucose utilization can be impaired due to reduced GK expression caused by the defective HNF-4.
The 5h-flanking region of the PK L promoter contains an HNF-4 responsive element, called L3 box. It has been shown that overexpression of HNF-4 results in activation of the PK L promoter [39] . The PK L gene is positively regulated in the presence of insulin by glucose and negatively regulated by glucagon via cAMP [48, 49] . In this way, HNF-4 is phosphorylated by protein kinase A suppressing the binding of HNF-4 to the L3 box [50] . These results indicate that HNF-4 is phosphorylated by protein kinase A and therefore HNF-4 might be involved in the transcriptional inhibition of liver genes, e.g. by glucagon via cAMP. Thus, it appears that HNF-4 is a possible candidate regulating the inhibition of insulin-mediated GK induction by glucagon.
HNF-4 as a cofactor regulating the O 2 -dependent gene expression
The findings of this study, namely that perivenous pO # enhanced the levels and the binding of HNF-4 to the GK-HNF-4 element clearly indicate that HNF-4 might act as a regulatory factor mediating the perivenous zonated GK expression in the liver acinus. This is also supported by the results of a study [51] , which showed that HNF-4 mRNA levels were enhanced in perivenous cell lysates compared with periportal cell lysates and that a higher HNF-4 content was detected in the less aerobic perivenous region of the rat liver. Furthermore, it was demonstrated that HNF-4 bound as a transcriptional activator to a region within the hypoxia-sensitive EPO enhancer, thereby enhancing the hypoxia-induced EPO gene expression [27] . These findings together with the results of our study suggest that HNF-4α might play a role in the O # -mediated zonated GK expression in rat liver.
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